KR890000184B1 - 신규 6-치환-s-트리아졸로[3,4-a]프탈라진 유도체의 제조방법 - Google Patents

신규 6-치환-s-트리아졸로[3,4-a]프탈라진 유도체의 제조방법 Download PDF

Info

Publication number
KR890000184B1
KR890000184B1 KR1019830000174A KR830000174A KR890000184B1 KR 890000184 B1 KR890000184 B1 KR 890000184B1 KR 1019830000174 A KR1019830000174 A KR 1019830000174A KR 830000174 A KR830000174 A KR 830000174A KR 890000184 B1 KR890000184 B1 KR 890000184B1
Authority
KR
South Korea
Prior art keywords
group
substituted
formula
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830000174A
Other languages
English (en)
Korean (ko)
Other versions
KR840003254A (ko
Inventor
옥셀리 에밀리오
바론 도메니코
타르지아 기오르기오
기운타 아델
Original Assignee
그루포 레페티트 에스.피.에이
레나토 스가르비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 그루포 레페티트 에스.피.에이, 레나토 스가르비 filed Critical 그루포 레페티트 에스.피.에이
Publication of KR840003254A publication Critical patent/KR840003254A/ko
Application granted granted Critical
Publication of KR890000184B1 publication Critical patent/KR890000184B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1019830000174A 1982-01-18 1983-01-18 신규 6-치환-s-트리아졸로[3,4-a]프탈라진 유도체의 제조방법 Expired KR890000184B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18
GB8201273 1982-01-18

Publications (2)

Publication Number Publication Date
KR840003254A KR840003254A (ko) 1984-08-20
KR890000184B1 true KR890000184B1 (ko) 1989-03-09

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830000174A Expired KR890000184B1 (ko) 1982-01-18 1983-01-18 신규 6-치환-s-트리아졸로[3,4-a]프탈라진 유도체의 제조방법

Country Status (20)

Country Link
US (1) US4788186A (instruction)
EP (1) EP0085840B1 (instruction)
JP (1) JPS58124786A (instruction)
KR (1) KR890000184B1 (instruction)
AT (1) ATE22562T1 (instruction)
AU (1) AU564026B2 (instruction)
CA (1) CA1214168A (instruction)
DE (1) DE3366494D1 (instruction)
DK (1) DK163145C (instruction)
ES (1) ES8601995A1 (instruction)
FI (1) FI81350C (instruction)
GR (1) GR78442B (instruction)
HU (1) HU193033B (instruction)
IE (1) IE55032B1 (instruction)
IL (1) IL67697A (instruction)
NO (1) NO161674C (instruction)
NZ (1) NZ203021A (instruction)
PH (1) PH21834A (instruction)
PT (1) PT76107A (instruction)
ZA (1) ZA83224B (instruction)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
EP0915877A1 (en) 1996-07-25 1999-05-19 MERCK SHARP & DOHME LTD. SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABA A?$g(a)5 RECEPTOR SUBTYPE
ES2194205T3 (es) 1996-07-25 2003-11-16 Merck Sharp & Dohme Derivados de triazolo-piridazina sustituidos como ligandos para los receptores gaba.
ES2179490T3 (es) * 1997-05-08 2003-01-16 Merck Sharp & Dohme Derivados de 1,2,4-triazolo(3,4-a)ftalazina sustituidos como ligandos de gaba alfa 5.
GB9715977D0 (en) * 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
WO1999025353A1 (en) * 1997-11-13 1999-05-27 Merck Sharp & Dohme Limited Therapeutic uses of triazolo-pyridazine derivatives
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
AU746866B2 (en) 1998-01-14 2002-05-02 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801210D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
IL136442A0 (en) 1998-01-21 2001-06-14 Merck Sharp & Dohme Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) * 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
CN1291194A (zh) * 1998-02-25 2001-04-11 默克·夏普-道姆公司 取代的1,2,4－三唑并[3,4－a]哒嗪
CZ291302B6 (cs) 1998-02-25 2003-01-15 Merck Sharp & Dohme Limited Substituovaný 1,2,4-triazolo[3,4-a]ftalazinový derivát
WO2000027849A2 (en) 1998-11-12 2000-05-18 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
AU2002307163B2 (en) * 2001-04-10 2006-06-29 Merck & Co., Inc. A method of treating cancer
US6958334B2 (en) * 2001-04-10 2005-10-25 Merck & Co., Inc. Inhibitors of Akt activity
AU2003226301A1 (en) * 2002-04-08 2003-10-20 Merck And Co., Inc. Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
CA2578368C (en) * 2004-09-02 2013-07-02 Altana Pharma Ag Triazolophthalazines
CA2591991C (en) * 2005-01-05 2013-11-19 Altana Pharma Ag Triazolophthalazines
EA012505B1 (ru) 2005-01-05 2009-10-30 Никомед Гмбх Триазолофталазины в качестве ингибиторов pde-2
PH12012501361A1 (en) 2009-12-31 2012-10-22 Centro Nac De Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 Ｓ―トリアゾロ〔３，４ ―α〕〔５，６，７，８〕テトラヒドロ フタラジン類
GR70309B (instruction) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
AU1055083A (en) 1983-07-28
CA1214168A (en) 1986-11-18
IL67697A (en) 1990-02-09
DK163145B (da) 1992-01-27
IE55032B1 (en) 1990-05-09
DK163145C (da) 1992-06-22
AU564026B2 (en) 1987-07-30
DK17983D0 (da) 1983-01-18
DK17983A (da) 1983-07-19
DE3366494D1 (de) 1986-11-06
FI830100A0 (fi) 1983-01-12
ZA83224B (en) 1983-10-26
FI81350B (fi) 1990-06-29
NO161674C (no) 1989-09-13
PH21834A (en) 1988-03-17
IL67697A0 (en) 1983-05-15
ATE22562T1 (de) 1986-10-15
GR78442B (instruction) 1984-09-27
ES531458A0 (es) 1985-11-01
FI81350C (fi) 1990-10-10
HU193033B (en) 1987-08-28
NO830110L (no) 1983-07-19
ES8601995A1 (es) 1985-11-01
KR840003254A (ko) 1984-08-20
NO161674B (no) 1989-06-05
US4788186A (en) 1988-11-29
EP0085840A1 (en) 1983-08-17
JPH048428B2 (instruction) 1992-02-17
IE830082L (en) 1983-07-18
PT76107A (en) 1983-02-01
NZ203021A (en) 1986-05-09
EP0085840B1 (en) 1986-10-01
FI830100L (fi) 1983-07-19
JPS58124786A (ja) 1983-07-25

Similar Documents

Publication Publication Date Title
KR890000184B1 (ko) 신규 6-치환-s-트리아졸로[3,4-a]프탈라진 유도체의 제조방법
EP2281815B1 (en) 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound
RU2118317C1 (ru) (-)-[[4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил]гидразоно]пропандинитрил и его фармацевтически приемлемые соли, фармацевтическая композиция на его основе, способ получения промежуточного соединения и способ получения целевого соединения
KR890000637B1 (ko) 1,2,4-트리아졸-3-온 항우울증제 및 그 제조방법
EP0264586B1 (en) Hydantoin derivatives for treating complications of diabetes
EP0134946B1 (en) 3,6-Disubstituted-triazolo[3,4-a]phthalazine derivatives
JPS6157587A (ja) 縮合複素環誘導体および抗潰瘍剤
US5840895A (en) Triazole intermediates for tricyclic benzazepine and benzothiazepine derivatives
EP0521768B1 (fr) Nouveaux dérivés de triazolopyrimidine antagonistes des récepteurs à l'angiotensine II; leurs procédés de préparation, compositions pharmaceutiques les contenant
CH674368A5 (instruction)
EP0217700A1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
KR900005836B1 (ko) 1,2,4-트리아조로[4,3-c]피리미딘
EP0201765B1 (en) 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
JPS6231719B2 (instruction)
HU192653B (en) Process for the production of imidazo /1,2-c/pyrimidines, as well as of therapeutic preparations containing these compounds as agent
CA1088059A (en) Piperazinyl and homopiperazinyl quinazolines
US4053600A (en) Tricyclic 1,2,4-triazolo-quinazolines
EP0628045A1 (fr) Derives de pyrazolopyrimidines antagonistes des recepteurs a l'angiotensine ii
KR920000271B1 (ko) 1,2,4-트리아조로[1,5-c] 피리미딘 및 이의 제조방법
US7148222B2 (en) Substituted pyrido-pyridazine derivatives which enhance cognition via the GABA-A receptors
EP0233745A2 (en) Chemical compounds
KR900008550B1 (ko) 피라졸로[3,4-b]피리딘 유도체의 제조 방법
WO1991017973A1 (en) 5H-DIBENZO(a,d)CYCLOHEPTENES AS MUSCARINIC RECEPTOR ANTAGONISTS
JPH0676414B2 (ja) ベンゼン縮合複素環化合物
HK1149563B (en) 4-(acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1h-indole-1-acetic acid ethyl ester intermediate compound

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

FPAY Annual fee payment

Payment date: 19920207

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19930310

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19930310

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000